bovnews14h
Moderna Inc (MRNA) Stock Price Reaches $41.51: What Factors Are Influencing This Level?
On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $41.51 which represents a decrease of $-4.14 or -9.07% from the prior close of $45.65. The stock opened at $45.36 and touched a ...
BofA restarts coverage of 11 large-cap biopharmas
BofA has reinstated coverage of 11 large-cap pharmaceutical and biotech stocks, with Eli Lilly (NYSE:LLY), Gilead ...
BofA downgrades Moderna, says it's 'tough time' to be vaccine maker
Moderna (MRNA) shares tumble after Bank of America analysts reinstated its Underperform rating for the stock. In a broader note about the pharmaceutical and biotech spaces, Bank of America's team it's ...
Alert on 3 Stocks on Sale
BofA (BAC) analysts restarted their coverage on 11 large-capitalization pharmaceutical and biotech firms. The bad news was ...
Benzinga.com1mon
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
BofA Securities notes that Moderna’s stock rose early Thursday but ended the day lower, likely due to slowing vaccine trends and uncertainty around the company’s respiratory vaccine lineup ...
Pfizer reinstated with a Neutral at BofA
BofA reinstated coverage of Pfizer (PFE) with a Neutral rating and $29 price target Uncertainty over COVID revenue streams plus a “tough” base ...
Wall St indexes fall with inflation data and rates in focus
Wall Street's main indexes closed lower on Tuesday as technology sector losses offset gains in communications services while ...